Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
54.1 USD | +0.04% | +3.96% | -13.82% |
06:28pm | Ligand Pharmaceuticals Investing in Agenus to Fund Development of Oncology Drug Candidates | MT |
May. 01 | TD Cowen Adjusts Price Target on Incyte to $80 From $88 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.82% | 12.14B | |
-2.47% | 88.14B | |
+3.29% | 40.44B | |
-15.64% | 32.24B | |
+51.96% | 24.39B | |
-14.57% | 15.59B | |
-39.65% | 12.3B | |
-6.52% | 12.18B | |
+5.17% | 8.87B | |
-6.67% | 8.41B |
- Stock Market
- Equities
- INCY Stock
- News Incyte Corporation
- Goldman Sachs Adjusts Price Target on Incyte to $98 From $114, Keeps Buy Rating